- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 5 residues within 4Å:- Chain A: H.129, V.132, E.134, K.173, N.175
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 8 residues within 4Å:- Chain A: D.313, N.340, F.341, N.342, L.597
- Chain C: D.516, P.517, R.518
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.516
NAG-NAG.4: 3 residues within 4Å:- Chain A: D.702, N.713, T.715
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 7 residues within 4Å:- Chain A: V.1201, N.1202
- Chain B: D.869, V.870, D.871, N.872, Q.992
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.869, B:N.872
NAG-NAG.6: 2 residues within 4Å:- Chain B: N.16, V.19
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 3 residues within 4Å:- Chain B: H.129, V.132, N.175
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 9 residues within 4Å:- Chain A: Y.515, D.516, P.517, R.518
- Chain B: D.313, N.340, N.342, N.594, L.597
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 2 residues within 4Å:- Chain B: V.651, N.653
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 4 residues within 4Å:- Chain B: D.606, Y.688, N.691, N.692
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 5 residues within 4Å:- Chain B: F.701, D.702, N.713, T.715, D.716
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 7 residues within 4Å:- Chain B: V.1201, N.1202
- Chain C: D.869, V.870, D.871, N.872, Q.992
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:D.869, C:N.872
NAG-NAG.14: 2 residues within 4Å:- Chain C: N.6, N.9
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 2 residues within 4Å:- Chain C: N.45, N.259
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 3 residues within 4Å:- Chain C: N.179, S.181, T.182
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 2 residues within 4Å:- Chain C: V.651, N.653
No protein-ligand interaction detected (PLIP)NAG-NAG.20: 4 residues within 4Å:- Chain C: H.671, N.673, Y.734, N.735
No protein-ligand interaction detected (PLIP)NAG-NAG.21: 5 residues within 4Å:- Chain C: T.605, D.606, Y.688, N.691, N.692
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:T.605
NAG-NAG.22: 4 residues within 4Å:- Chain C: D.702, N.713, T.715, D.716
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.17: 5 residues within 4Å:- Chain C: H.129, V.132, E.134, K.173, N.175
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.23: 7 residues within 4Å:- Chain A: D.869, V.870, D.871, N.872, Q.992
- Chain C: V.1201, N.1202
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.872, A:N.872
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.24: 3 residues within 4Å:- Chain A: N.6, N.9
- Ligands: NAG-NAG-BMA-MAN-MAN.1
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: N.16, V.19
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain A: N.45, N.259
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain A: F.10, S.156, N.158
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain A: N.179, S.181, T.182
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain A: S.234, T.236, D.237, N.238
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: F.323, I.419, N.420
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: N.457, T.459, K.523
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: S.549, N.551
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain A: V.651, N.653
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain A: H.671, N.673, Y.734
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: D.606, N.691, N.692
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: S.720, P.760, N.762
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain A: N.767
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain A: N.784, I.1142
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain A: E.911, N.915, S.920
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: N.6, N.9
- Ligands: NAG-NAG-BMA-MAN-MAN.7
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain B: N.45
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain B: F.10, N.158
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: N.179, S.181, T.182
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain B: S.234, T.236, N.238
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain B: F.323, N.420
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain B: N.457, T.459, S.521
- Chain C: D.84
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain B: N.551
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain B: H.671, N.673, Y.734, N.735
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain B: S.720, P.760, N.762
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain B: N.767
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain B: N.784
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain B: E.911, N.914, N.915
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain C: N.16, V.19
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain C: F.10, N.158
Ligand excluded by PLIPNAG.57: 4 residues within 4Å:- Chain C: S.234, T.236, D.237, N.238
Ligand excluded by PLIPNAG.58: 7 residues within 4Å:- Chain B: A.514, Y.515
- Chain C: D.313, N.340, F.341, N.342, L.597
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain C: F.323, I.419, N.420
Ligand excluded by PLIPNAG.60: 2 residues within 4Å:- Chain C: N.457, S.521
Ligand excluded by PLIPNAG.61: 2 residues within 4Å:- Chain C: S.720, N.762
Ligand excluded by PLIPNAG.62: 1 residues within 4Å:- Chain C: N.767
Ligand excluded by PLIPNAG.63: 1 residues within 4Å:- Chain C: N.784
Ligand excluded by PLIPNAG.64: 3 residues within 4Å:- Chain C: E.911, A.912, N.915
Ligand excluded by PLIP- 3 x 01: 5-acetamido-8-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
01.40: 17 residues within 4Å:- Chain A: N.13, L.15, T.17, T.18, L.66, K.67, G.68, T.69, T.70, Y.71, L.72, S.73, W.76, N.230, A.231, S.233, N.235
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:T.18, A:L.66
- Hydrogen bonds: A:N.13, A:T.17, A:T.17, A:K.67, A:K.67, A:K.67, A:T.69, A:T.69, A:T.69, A:T.70, A:S.233, A:N.235
- Salt bridges: A:K.67
01.54: 18 residues within 4Å:- Chain B: N.13, L.15, T.17, T.18, L.66, K.67, G.68, T.69, Y.71, L.72, S.73, W.76, C.229, N.230, A.231, S.233, N.235, T.236
18 PLIP interactions:18 interactions with chain B- Hydrophobic interactions: B:L.15, B:T.17, B:T.18, B:L.66, B:W.76, B:T.236
- Hydrogen bonds: B:N.13, B:T.17, B:T.17, B:K.67, B:K.67, B:K.67, B:T.69, B:T.69, B:T.69, B:S.233, B:N.235
- Salt bridges: B:K.67
01.65: 14 residues within 4Å:- Chain C: N.13, L.15, T.17, L.66, K.67, G.68, T.69, Y.71, S.73, W.76, N.230, A.231, S.233, N.235
13 PLIP interactions:13 interactions with chain C- Hydrophobic interactions: C:T.17, C:L.66, C:Y.71, C:W.76
- Hydrogen bonds: C:N.13, C:T.17, C:K.67, C:T.69, C:T.69, C:T.69, C:S.233, C:N.235
- Salt bridges: C:K.67
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, M. et al., Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes. Nat Commun (2025)
- Release Date
- 2025-05-14
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 39 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x 01: 5-acetamido-8-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, M. et al., Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes. Nat Commun (2025)
- Release Date
- 2025-05-14
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C